ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,067.70
0.92%
Dow Jones
44,850.35
0.31%
US Dollar vs MXN
20.5546
-0.91%
Brent Oil
76.575
0.40%
Bitcoin
100,557.42
-1.48%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Alligator Bioscience Ab (0RK9) Cotización

Alligator Bioscience Ab

Alligator Bioscience Ab (0RK9)

LSE
23.00
0.00
(0.00%)
Cerrado 28 Enero 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
23.00
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
83,641
0.00 Rango del Día 0.00
23.00 Rango de 52 semanas 23.00
Capitalización de Mercado [m]
15.133B
Precio Anterior
23.00
Precio de Apertura
-
Hora
83641
@
0.299
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
14,339
Acciones en circulación
657,954,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.58
Beneficio por acción (BPA)
-0.38
turnover
59.27M
Beneficio neto
-248.59M

Acerca de Alligator Bioscience Ab

Sector
Noncomml Resh Organizations
Industria
Noncomml Resh Organizations
Sitio web
www.alligatorbioscience.se
Sede
Lund, Swe
Fundado
-
Alligator Bioscience Ab is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker 0RK9. The last closing price for Alligator Bioscience Ab was SEK23. Over the last year, Alligator Bioscience Ab shares have traded in a share price range of SEK 23.00 to SEK 23.00.

Alligator Bioscience Ab currently has 657,954,000 shares in issue. The market capitalisation of Alligator Bioscience Ab is SEK15.13 billion. Alligator Bioscience Ab has a price to earnings ratio (PE ratio) of -0.58.

0RK9 Últimas noticias

Más noticias

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

01 Abril 2022
PR Newswire (US)

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

01 Abril 2022
PR Newswire (US)

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

23 Marzo 2022
PR Newswire (US)

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

23 Marzo 2022
PR Newswire (US)

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

11 Febrero 2022
PR Newswire (US)

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

11 Febrero 2022
PR Newswire (US)

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

01 Febrero 2022
PR Newswire (US)

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

01 Febrero 2022
PR Newswire (US)

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

19 Enero 2022
PR Newswire (US)

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

19 Enero 2022
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1002323235280523DE
4002323231575723DE
12002323231433923DE
2600232323694423DE
5200232323390923DE
15600232323240623DE
26000232323225523DE

0RK9 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Alligator Bioscience Ab?
El precio actual de las acciones de Alligator Bioscience Ab es SEK 23.00
¿Cuántas acciones de Alligator Bioscience Ab están en circulación?
Alligator Bioscience Ab tiene 657,954,000 acciones en circulación
¿Cuál es la capitalización de mercado de Alligator Bioscience Ab?
La capitalización de mercado de Alligator Bioscience Ab es SEK 15.13B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Alligator Bioscience Ab?
Alligator Bioscience Ab ha negociado en un rango de SEK 23.00 a SEK 23.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Alligator Bioscience Ab?
El ratio precio/beneficio de Alligator Bioscience Ab es -0.58
¿Cuál es el ratio de efectivo a ventas de Alligator Bioscience Ab?
El ratio de efectivo a ventas de Alligator Bioscience Ab es 2.44
¿Cuál es la moneda de reporte de Alligator Bioscience Ab?
Alligator Bioscience Ab presenta sus resultados financieros en SEK
¿Cuál es el último ingresos anual de Alligator Bioscience Ab?
El último ingresos anual de Alligator Bioscience Ab es SEK 59.27M
¿Cuál es el último beneficio anual de Alligator Bioscience Ab?
El último beneficio anual de Alligator Bioscience Ab es SEK -248.59M
¿Cuál es la dirección registrada de Alligator Bioscience Ab?
La dirección registrada de Alligator Bioscience Ab es MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 81
¿Cuál es la dirección del sitio web de Alligator Bioscience Ab?
La dirección del sitio web de Alligator Bioscience Ab es www.alligatorbioscience.se
¿En qué sector industrial opera Alligator Bioscience Ab?
Alligator Bioscience Ab opera en el sector NONCOMML RESH ORGANIZATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CHFChesterfield Resources Plc
0.40p
(33.33%)
580.46k
DIADialight Plc
119.00p
(29.70%)
514.97k
SAASMicrolise Group Plc
117.00p
(27.17%)
783.4k
NFXNuformix Plc
0.145p
(26.09%)
1.06B
BLOEBlock Energy Plc
0.80p
(23.08%)
10.86M
SCGLSealand Capital Galaxy Limited
5.75p
(-23.33%)
11.33M
CLAICel Ai Plc
0.27p
(-21.74%)
31.9M
TYMTertiary Minerals Plc
0.0525p
(-19.23%)
123.41M
DGIDg Innovate Plc
0.0175p
(-18.60%)
144.64M
TRCThe Revel Collective Plc
0.225p
(-18.18%)
2.03M
NFXNuformix Plc
0.145p
(26.09%)
1.06B
VRSVersarien Plc
0.035p
(1.45%)
994.63M
NTVONativo Resources Plc
0.0019p
(-9.52%)
693.14M
UOGUnited Oil & Gas Plc
0.115p
(17.95%)
360.68M
TRPTower Resources Plc
0.0295p
(0.00%)
320.63M

Discusión

Ver feed completo
BullNBear52 BullNBear52 50 segundos hace
U.S. Navy bans use of DeepSeek due to ‘security and ethical concerns’
Published Tue, Jan 28 20255:16 PM ESTUpdated 5 Min Ago
https://www.cnbc.com/2025/01/28/us-navy-restricts-use-of-deepseek-ai-imperative-to-avoid-using.html

Well that didn't take long.
price_and_volume price_and_volume 1 minuto hace
You asked about fraud.

That case is about fraud.

If you want a felony case number, maybe wait a bit or just call JK again and ask him.

My guess is there are likely current shareholder-cases being brought against him by those mentioned in Washington's case
VXIT
maryj55555 maryj55555 2 minutos hace
Close at 3. Not great. 
TKMO
12yearplan 12yearplan 2 minutos hace
Linamar to spend nearly $1.1 billion on set of Ontario EV projects
https://finance.yahoo.com/news/linamar-spend-nearly-1-1-132724429.html?_guc_consent_skip=1738102850
In 2021, Linamar formed eLIN Product Solutions Group, which focused on power generation, power storage, propulsion syst
EXROF
threewheeler threewheeler 2 minutos hace
yes but anyone can hide bids and asks by placing all or none any wayz so no big deal to me, I never sell bids, place ur sells and wait til market comes for them always my play
KRTL
zab zab 2 minutos hace
Of course they did, and America is better off.
Lacey1 Lacey1 3 minutos hace
You nailed it. I have never participated in a short squeeze, they always seem to get out. What happens to the price of a stock that is 95% institutional owned and the reported short position is greater than those held by retail.
AVXL
SuperSpreader SuperSpreader 3 minutos hace
I have been out for a bit. Can someone explain the investment in The Plant and why its now a landing page for some video game platform in a slavic language? https://www.theplantlabs.com/
NNRX
Bayguy Bayguy 3 minutos hace
I thought that was Cgrowth Capital's Function. 
CGRA
bri123 bri123 3 minutos hace
OS increased to 2,931,748,492 01/28/2025
Restricted 359,757,921 01/28/2025
Unrestricted 2,571,990,571 01/28/2025

OS 2,755,899,349 01/27/2025
Restricted 359,757,921 01/27/2025
Unrestricted 2,396,141,428 01/27/2025
THBD
ergo sum ergo sum 3 minutos hace
Convicted of 34 felonies Trump insists he was not guilty of, why is he still using the same lawyer to defend his policies as President?
Bring The Heat Bring The Heat 4 minutos hace
What event happens on 2/28?
HMBL
mahatmapaul mahatmapaul 5 minutos hace
You're being too charitable! $0.174 to $0.0125
XCRT
Phantom Lord Phantom Lord 5 minutos hace
The company used to, under prior management, trickle data out a few patients at a time. It was poor practice and never really worked out for them. In my precious discussions with Vera he seemed intent on not doing that anymore and holding back data so the release would be more meaningful. Now this p
MRKR
thirdcoast thirdcoast 5 minutos hace
https://www.reuters.com/business/energy/venture-global-given-ok-introduce-natgas-another-lng-plant-output-ramps-up-2025-01-28/
TGLO
Monroe1 Monroe1 6 minutos hace
It's all about right and wrong. It is coming down to that. PFE will pay the piper.

New era has emerged. Let's see how all this plays out. The past has a way of catching up if overlooked.

Pfizer would be smart to somehow make amends for past mistakes in regards to mRna
PFE
Major Profits Major Profits 6 minutos hace
Dec. 19, 2024
Share price closed at .0316

Jan. 28, 2025
Share price closed at .0147
https://media0.giphy.com/media/WUlPyyKnvASMGBkzc1/200w.gif?cid=82a1493b5d7u0a722kqg8rsg3clzkynpnd5konpt86kobx4l&ep=v1_gifs_related&rid=200w.gif&ct=s

https://investo
BCDS
seve333 seve333 6 minutos hace
It was likely just one buyer it certainly is not a BB or there is no news. I am still trying to figure out what in heck Denner intends to do to get this over a buck. Or maybe as you have said he does not want it to go over a buck. I am guess the earnings wont be great so we probably drop again on th
AMRN
Number sleven Number sleven 6 minutos hace
JRoon, Thanks. I'll probably see it in the morning.
Sleven,
AMRN
FeMike FeMike 6 minutos hace
I’m not sure why you’re telling me this Flip.

I told you all of this information almost verbatim 5 months before LP confirmed any of.

You told me I was wrong. My point is that I was, in fact, not wrong. While what you said you knew to be a fact (the PIP must be initiat
NWBO
TheSprinx TheSprinx 7 minutos hace
The stars are aligning boys and girls.
"Literally". 
And when they do..........Feb 28th to be exact......
Ha. Boom!
HMBL
Uncle Monkey Uncle Monkey 7 minutos hace
what terrible mgmt.... expect. 0002 SOON
CBRF
Brodey79 Brodey79 7 minutos hace
To put a value on FDCT just compare it with Etoro. Same type of company. Etoro was going to go public before for 10.5 billion dollars. Etoro does have huge revenues of 630-650 million dollars. That would put it at multiples between 16 and 17. Do that on the book price with FDCT and Bobs your uncle.
FDCT
shoondale shoondale 7 minutos hace
Lookie! Lookie!...This is one talented family serving ADTX... https://www.aditxt.com/about/leadership/ https://www.aditxt.com/about/leadership/
Amro Albanna https://www.aditxt.com/wp-content/uploads/2021/07/amrose-albanna-bio.jpg
Co-founder and Chief Executive Officer
Founded
ADTX
Uncle Monkey Uncle Monkey 7 minutos hace
how sad mgmt can't update shareholders

pathetic!!!
CBRF

Su Consulta Reciente

LSE
0RK9
Alligator Bioscience Ab
BIT
EST
ETF
BIT
UI936C
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados